2m 2m 2m 2m 2m 2m 2m
KALARIS THERAP (KLRS)
NASDAQ
$2.70-$0.15 (-5.23%)
Price as of Oct 02, 2026 5:08 PM EDT- $67.8MMarket Cap
- -59.80%1-Year Change
- BiotechnologyIndustry
KALARIS THERAP (KLRS)
$2.70-$0.15 (-5.23%)
KLRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.85 | ||
Change | -$0.04 (-1.38%) | ||
Open | $2.88 | ||
High | $2.89 | ||
Low | $2.76 | ||
Previous Close | $2.89 | ||
Volume | 58,621 | ||
30-Day Average Volume | 69,093 | ||
1-Week Change | -7.17% | ||
1-Month Change | -27.30% | ||
1-Year Change | -59.80% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 23.8M | ||
Total Assets | $99.5M | ||
Market Cap | $67.8M | ||
Enterprise Value | $24.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$11.5M | ||
Free Cash Flow | -$11.0M | ||
EBIT | -$11.5M | ||
EBITDA | -$11.5M | ||
Net Working Capital | $87.2M | ||
EPS | -$0.48 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | 1 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue